1. Home
  2. AEC vs CSBR Comparison

AEC vs CSBR Comparison

Compare AEC & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anfield Energy Inc.

AEC

Anfield Energy Inc.

HOLD

Current Price

$4.16

Market Cap

73.1M

Sector

Real Estate

ML Signal

HOLD

Logo Champions Oncology Inc.

CSBR

Champions Oncology Inc.

N/A

Current Price

$5.81

Market Cap

81.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AEC
CSBR
Founded
1989
1985
Country
Canada
United States
Employees
15
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.1M
81.0M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
AEC
CSBR
Price
$4.16
$5.81
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
55.8K
5.5K
Earning Date
05-01-2015
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
161.11
EPS
N/A
N/A
Revenue
N/A
$2,900,000.00
Revenue This Year
N/A
$4.84
Revenue Next Year
N/A
$11.51
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.66
$5.50
52 Week High
$12.49
$8.74

Technical Indicators

Market Signals
Indicator
AEC
CSBR
Relative Strength Index (RSI) 45.80 44.19
Support Level N/A $5.66
Resistance Level $5.26 $6.31
Average True Range (ATR) 0.32 0.41
MACD 0.02 -0.06
Stochastic Oscillator 12.88 21.76

Price Performance

Historical Comparison
AEC
CSBR

About AEC Anfield Energy Inc.

Anfield Energy Inc is a mineral exploration and development company. This company focuses on uranium and vanadium development and near-term production. The exploration project of the company includes Shootaring Canyon Mill and Velvet-Wood and Slick Rock Uranium Project from Uranium One and The West Slope Project located in Montrose and San Miguel Counties in southwestern Colorado. The company's geographical segments are Canada and the United States.

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

Share on Social Networks: